Zomedica Pharmaceuticals Inc., a Delaware incorporated company located in Ann Arbor, Michigan, is a wholly-owned subsidiary of Zomedica Pharmaceuticals Corp., a Canadian corporation, both founded in May 2015.
Zomedica’s vision and mission is to advance the health, effectiveness and financial well-being of companion animal veterinarians by delivering economically and professionally beneficial products and services. In short, Zomedica is committed to advancing animal health and veterinarian success.
According to a report prepared by Brakke Consulting, a firm serving companies in animal health and nutrition, pet care, and veterinary services, the global animal health market for pharmaceuticals, biologicals and parasiticides was an estimated US$24 billion in 2014. Of that, approximately 41 percent or US$9.8 billion was consumed within the companion animal segment (dogs, cats, horses) with Westernized areas such as North America, Europe and Japan representing the greatest market opportunity. The United States is the single largest companion animal market on the planet at an estimated US$4.2 billion. Additionally, there are more than 57,000 companion animal veterinarians practicing in the U.S., according to 2014 data from the American Veterinary Medical Association.
The companion animal space presents an attractive opportunity for market penetration and expansion via prescriptive therapeutics, devices, diagnostics and other needs-based veterinary solutions. An underserved demographic, companion animal veterinarians contend with numerous factors that impact both their professional and personal satisfaction. Zomedica believes all of these factors create potential demand for solutions that lower costs, increase productivity and grow revenue while advancing animal health.
There are three key differentiators that set Zomedica apart from many of its competitors in the animal health space:
Zomedica is listed on the TSX Venture Exchange (TSX-V) under the symbol ZOM.
Zomedica first listed on the TSX-V for three distinct reasons:
111 Richmond Street West, Suite 300
Toronto ON M5H 2G4
AST Trust Company (Canada)
formerly CST Trust Company
Phone: 1. 800.387. 0825 or 1.416.682.3860
Courier or Hand Delivery:
CST Trust Company
2001 Boul. Robert-Bourassa
Montreal, QC H3A 2A6
CST Trust Company
PO Box 700
Montreal, QC H3B 3K3
Zomedica’s fiscal year ends December 31.
Information on Zomedica’s board of directors can be found here
Information on Zomedica’s management team can be found here
For all investor inquiries with Zomedica, please email firstname.lastname@example.org or call 1. 734.369.2555 ext.113.
Complete the form below to receive automated email alerts on the latest news from Zomedica.
Copyright © 2016 - 2017 Zomedica Pharmaceuticals Corp. and Zomedica Pharmaceuticals Inc. All Rights Reserved.